Ys. Choong et al., PROTECTIVE EFFECTS OF OXYGENATED ST-THOMAS-HOSPITAL CARDIOPLEGIC SOLUTION DURING ISCHEMIC CARDIAC-ARREST - IMPROVED FUNCTION, METABOLISM AND ULTRASTRUCTURE, Journal of Cardiovascular Surgery, 34(5), 1993, pp. 423-433
The isolated working rat heart model was use to define the cardioprote
ctive effects (function, metabolic and ultrastructure) of the oxygenat
ed St. Thomas' Hospital No. 2 cardioplegic solution (STH) during lengt
hy, hypothermic ischaemia (20 degrees C, 4 hours and 5 hours). Hearts
(n = 9 for each group) were arrested with and exposed to multidose rei
nfusion (2 min every 40 min interval) throughout the ischaemic period
with the cold (4 degrees C) STH or oxygenated(95% O-2:5% CO2) STH. Oxy
genated STH significantly (p < 0.01) improved the postischaemic recove
ry of cardiac output from 49.5 +/- 11.1% to 96.8 +/- 1.5% (in 4 hours)
and from 20.3 +/- 7.2% to 72.2 +/- 5% (in 5 hours). Other indices of
functional recovery showed similar improved performance with the signi
ficant decrease in time from the onset of reperfusion to the return of
regular sinus rhythm (57 +/- 8 v 495 +/- 150 s). The efflux of lactat
e during 5 hr ischaemic arrest was decreased (20.62 +/- 1.3 v 26.18 +/
- 1.73 mu mol/heart for oxygenated STH and STH, respectively, p < 0.05
) and the progressive increase in the coronary vascular resistance was
abolished in the oxygenated STH treated hearts. These improvements we
re associated with the reduction in the decline of the myocardial aden
osine triphosphate (14.49 +/- 2 v 3.3 +/- 0.19 mu mol/g dry wt), creat
ine phosphate (24.61 +/- 3.47 v 7.48 +/- 1.34 mu mol/g dry wt) and gua
nosine triphosphate (1.69 +/- 0.2 v 0.84 +/- 0.08 mu mol/g dry wt) dur
ing ischaemia, total resynthesis after reperfusion (ATP: 103% v 36%, C
P: 105% v 69% and GTP: 203% v 61% of control) and the total absence of
myocardial cells and microvasculature injuries in ischaemic (non-repe
rfused) hearts. These results confirm that the provision of additional
oxygen to the St. Thomas' Hospital solution (with 95% O-2:5% CO2) can
meet the metabolic demand of the ischaemic myocardium and thus increa
se the safe duration of cardiac arrest.